Fig. 5From: Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancerHMGB1 overexpression promoted the malignant progression in vivo. (a) Tumorigenesis experiment in nude mice with cisplatin and paclitaxel treatment. (b-c) Tumor volume curves of mice with cisplatin and paclitaxel treatment, respectively. (d) Representative HE staining results. Magnification, Ă—200. (e) Representative IHC results of the expression levels of HMBG1, LRP and MRP after cisplatin and paclitaxel treatment. Scale bar, 100Â ÎĽmBack to article page